Mr. Stephen Fair joined FogPharma as the Vice President, Finance in January 2020. As a member of the Executive Leadership Team, he leads the Finance function and plays a crucial role in crafting the company’s finance strategy, corporate strategic development, and helping across the board to ensure its success.
Mr. Fair comes to us from Agios Pharmaceuticals where he was most recently Program Team Lead for Agios’ Solid Tumor programs, responsible for the strategic direction and operational execution of three clinical and commercial stage oncology products. Previously at Agios he was the Senior Director and Head Financial Planning and Analysis, responsible for building out the strategic finance function at the rapidly growing company. Earlier in his career he was Director and Head of FP&A at Merrimack Pharmaceuticals, helping lead the company through its Initial Public Offering and subsequent secondary financings. He also worked as a health care consultant at Analysis Group, Inc.
Mr. Fair holds a B.A. in Economics from Yale University and an M.B.A. from Stanford Business School.